Molecular Responses with Ponatinib in Patients with Philadelphia Chromosome Positive (Ph+) Leukemia: Results From the PACE Trial
Year: 2012
Type: article
Source: Blood
Authors: Andreas Hochhaus, Dong-Wook Kim, Javier Pinilla-Ibarz, Philipp le Coutre, Ronald Paquette, Charles Chuah, Franck E. Nicolini, Jane Apperley, H. Jean Khoury, Moshe Talpaz, John F. DiPersio, Daniel DeAngelo, Elisabetta Abruzzese, Delphine Rea, Michele Baccarani, Martin C Muller, Carlo Gambacorti-Passerini, Stephane Wong, Stephanie Lustgarten, Victor M. Rivera, Tim Clackson, Christopher D. Turner, Frank G Haluska, Francois Guilhot, Michael W. Deininger, Timothy P. Hughes, John M Goldman, Neil Shah, Hagop M. Kantarjian, Jorge E. Cortes, The PACE Study Group
Institutions: Jena University Hospital, The Catholic University of Korea Seoul St. Mary's Hospital, Catholic University of Korea, Moffitt Cancer Center, Charité - Universitätsmedizin Berlin, University of California, Los Angeles, National University of Singapore, Singapore General Hospital, Duke-NUS Medical School, Hôpital Lyon Sud, Hammersmith Hospital, Imperial College London, Winship Cancer Institute, University of Michigan, Washington University in St. Louis, Dana-Farber Cancer Institute, University of Rome Tor Vergata, St. Eugenio Hospital, Hôpital Saint-Louis, Recherche clinique appliquée à l'hématologie, University of Bologna, University Medical Centre Mannheim, Medizinische Fakultät Mannheim, University of Milano-Bicocca, ARIAD Pharmaceuticals (United States), Centre Hospitalier Universitaire de Poitiers, University of Utah, Huntsman Cancer Institute, South Australia Pathology, Royal Adelaide Hospital, University of California, San Francisco, The University of Texas MD Anderson Cancer Center
Language: English
Subfield: Hematology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2548744074